Suppr超能文献

在美国实施移动卒中单元项目:为何、如何以及需要多少成本?

Implementing a mobile stroke unit program in the United States: why, how, and how much?

机构信息

The University of Texas School of Public Health, Houston.

Department of Neurology, The University of Texas Health Science Center at Houston, Houston.

出版信息

JAMA Neurol. 2015 Feb;72(2):229-34. doi: 10.1001/jamaneurol.2014.3618.

Abstract

IMPORTANCE

There are many ways a mobile stroke unit (MSU) might prove valuable for patients with ischemic and hemorrhagic stroke, such as earlier recognition, more accurate triage, improved management of blood pressure and other critical physiological variables, and eventually earlier implementation of effective therapies. The MSU may be particularly valuable for treatment of patients with acute ischemic stroke with tissue plasminogen activator (tPA) within 4.5 hours of symptom onset, the most evidence-based effective emergency treatment for the most prevalent stroke diagnosis.

OBJECTIVES

To review existing data on prehospital stroke treatment, especially relevant to MSU technology, to identify gaps in our understanding of MSU feasibility, especially relevant to applying the MSU strategy in the United States, and to describe the Houston MSU program and clinical trial.

EVIDENCE REVIEW

Published data from English-language journals in PubMed from 1995 to present reviewing early treatment with tPA and prehospital stroke evaluation and treatment.

FINDINGS

The MSU may result in an overall shift toward earlier evaluation and treatment with tPA, particularly into the first hour after symptom onset, leading to substantially better outcomes. As a result of improved clinical outcomes owing to earlier treatment, the costs of an MSU program may be offset by a reduction in the costs of long-term stroke care and an increase in quality-adjusted life-years, thereby supporting more widespread use of this technology. To make MSU deployment more practical, the vascular neurologist aboard the MSU must be replaced by a remote vascular neurologist connected to the MSU by telemedicine, reducing manpower requirements and costs.

CONCLUSIONS AND RELEVANCE

The MSU strategy could dramatically transform the way acute stroke is managed in the United States. A prospective study evaluating the logistics, outcomes, and cost-effectiveness of this approach is needed and under way.

摘要

重要性

移动卒中单元 (MSU) 对于缺血性卒中和出血性卒中患者可能有很多价值,例如更早地识别、更准确地分诊、改善血压和其他关键生理变量的管理,最终更早地实施有效治疗。MSU 对于治疗在症状发作后 4.5 小时内接受组织型纤溶酶原激活剂 (tPA) 的急性缺血性卒中患者特别有价值,tPA 是最常见的卒中诊断的最具循证有效的紧急治疗方法。

目的

回顾现有的院前卒中治疗数据,特别是与 MSU 技术相关的数据,以确定我们对 MSU 可行性的理解差距,特别是在美国应用 MSU 策略的相关差距,并描述休斯顿 MSU 计划和临床试验。

证据回顾

检索 1995 年至今在 PubMed 发表的英文期刊中的相关数据,综述了 tPA 的早期治疗以及院前卒中的评估和治疗。

发现

MSU 可能会导致整体向更早地评估和 tPA 治疗转移,特别是在症状发作后的第一个小时内,从而带来显著更好的结果。由于早期治疗导致临床结局改善,MSU 计划的成本可能会因长期卒中护理成本的降低和质量调整生命年的增加而得到弥补,从而支持更广泛地使用这种技术。为了使 MSU 的部署更具实用性,可以通过远程医疗将 MSU 上的血管神经科医生替换为与 MSU 连接的远程血管神经科医生,从而降低人力需求和成本。

结论和相关性

MSU 策略可以极大地改变美国急性卒中的管理方式。需要并正在进行一项前瞻性研究,以评估这种方法的物流、结果和成本效益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验